DNAprint Genomics (DNAG)

[IVRT]

DNAPrint genomics, Inc. Invited to Present at Genomic Partnering
Conference, San Francisco


September 06, 2000--SARASOTA, Fla.--(BUSINESS WIRE)--Sept. 6, 2000--DNAPrint
genomics, Inc., (Pink Sheets:DNAP), a Sarasota, Florida based genomics company,
announced today that it has been invited to present at the Genomic Partnering Conference,
March 3rd-4th, 2001, in San Francisco, California. The conference, which showcases the
emerging companies in the genomics field, is sponsored by the Cambridge Healthtech
Institute (http://www.healthtech.com) and serves as a forum through which companies
engaged in cutting-edge genomics research can continue to grow through partnership. At the
conference, Dr. Tony Frudakis and Dr. MyungHo Kim will present data outlining DNAPrint's
geometric modeling approach to genetic pattern discovery, as well as outline
accomplishments related to the construction of DNAPrint's high-resolution SNP and Haplotype
maps, software algorithms and pharmacogenomics knowledge base.

About DNAPrint genomics
DNAPrint genomics, Inc. provides practitioners of genomic research and personalized
medicine with a comprehensive system for complex trait dissection and patient classification.
DNAPrint genomics Inc. was founded by a group of scientists with research and commercial
experience in high-level mathematical modeling, programming and molecular genetics. For
more information about the company, please visit www.dnaprint.com.

Except for factual statements made herein, the information contained in this press release
consists of forward-looking statements that involve risks and uncertainties. The Company's
actual results could differ materially from those contained in such statements. Factors that
could cause or contribute to such differences include unexpected shortages of critical
components, rescheduling or cancellation of customer orders, the timing and market
acceptance of new product introductions by the Company and its competitors, and general
competition and price pressures in the marketplace.


For scientific inquiries please contact: Dr. Tony Frudakis at 941/351-4543.
All other inquiries please contact: Richard Craig Hall at 941/341-0136.


Except for factual statements made herein, the information contained in this press release
consists of forward-looking statements that involve risks and uncertainties. The Company's
actual results could differ materially from those contained in such statements. Factors that
could cause or contribute to such differences include unexpected shortages of critical
components, rescheduling or cancellation of customer orders, the timing and market
acceptance of new product introductions by the Company and its competitors, and general
competition and price pressures in the marketplace.



Copyright DNAprint genomics © 2000

1748 Independence Blvd. Ste D1
Sarasota, Florida 34234